Otter S - Search Results

1

Outcomes following adjuvant therapy for HER2-positive early breast cancer in the elderly.

Otter S, Ring A. Otter S, et al. Expert Rev Anticancer Ther. 2010 Aug;10(8):1265-72. doi: 10.1586/era.10.94. Expert Rev Anticancer Ther. 2010. PMID: 20735312 Review.

2

The Role of Biomarkers for the Prediction of Response to Checkpoint Immunotherapy and the Rationale for the Use of Checkpoint Immunotherapy in Cervical Cancer.

Otter SJ, Chatterjee J, Stewart AJ, Michael A. Otter SJ, et al. Clin Oncol (R Coll Radiol). 2019 Dec;31(12):834-843. doi: 10.1016/j.clon.2019.07.003. Epub 2019 Jul 19. Clin Oncol (R Coll Radiol). 2019. PMID: 31331818 Free article. Review.

3

Vascular endothelial growth factor (VEGF) targeting therapy for persistent, recurrent, or metastatic cervical cancer.

Chuai Y, Rizzuto I, Zhang X, Li Y, Dai G, Otter SJ, Bharathan R, Stewart A, Wang A. Chuai Y, et al. Cochrane Database Syst Rev. 2021 Mar 4;3(3):CD013348. doi: 10.1002/14651858.CD013348.pub2. Cochrane Database Syst Rev. 2021. PMID: 33661538 Free PMC article.

4

Cervical and Endometrial Cancer - A Tale of Two Halves?

Otter S, Stewart A. Otter S, et al. Clin Oncol (R Coll Radiol). 2021 Sep;33(9):547-549. doi: 10.1016/j.clon.2021.07.004. Epub 2021 Jul 29. Clin Oncol (R Coll Radiol). 2021. PMID: 34332840 No abstract available.

5

Adaptive Radiotherapy in the Management of Cervical Cancer: Review of Strategies and Clinical Implementation.

Shelley CE, Barraclough LH, Nelder CL, Otter SJ, Stewart AJ. Shelley CE, et al. Among authors: otter sj. Clin Oncol (R Coll Radiol). 2021 Sep;33(9):579-590. doi: 10.1016/j.clon.2021.06.007. Epub 2021 Jul 9. Clin Oncol (R Coll Radiol). 2021. PMID: 34247890 Review.

6

Improving dose delivery by adding interstitial catheters to fixed geometry applicators in high-dose-rate brachytherapy for cervical cancer.

Otter S, Coates A, Franklin A, Cunningham M, Stewart A. Otter S, et al. Brachytherapy. 2018 May-Jun;17(3):580-586. doi: 10.1016/j.brachy.2018.01.003. Epub 2018 Feb 14. Brachytherapy. 2018. PMID: 29426744

7

Modern Brachytherapy.

Otter SJ, Stewart AJ, Devlin PM. Otter SJ, et al. Hematol Oncol Clin North Am. 2019 Dec;33(6):1011-1025. doi: 10.1016/j.hoc.2019.08.011. Epub 2019 Oct 1. Hematol Oncol Clin North Am. 2019. PMID: 31668203 Review.

8

The Human Papillomavirus as a Common Pathogen in Oropharyngeal, Anal and Cervical Cancers.

Otter S, Whitaker S, Chatterjee J, Stewart A. Otter S, et al. Clin Oncol (R Coll Radiol). 2019 Feb;31(2):81-90. doi: 10.1016/j.clon.2018.10.004. Epub 2018 Oct 29. Clin Oncol (R Coll Radiol). 2019. PMID: 30385006 Free article. Review.

9

Low Dose Rate Brachytherapy Boost for High-risk Prostate Cancer: An Evidence-based Approach.

Mikropoulos C, Otter S, Perna C, Khaksar S, Franklin A, Laing R, Uribe J, Lewis SU, Langley S. Mikropoulos C, et al. Among authors: otter s. Clin Oncol (R Coll Radiol). 2020 Jul;32(7):e162. doi: 10.1016/j.clon.2020.03.007. Epub 2020 Apr 8. Clin Oncol (R Coll Radiol). 2020. PMID: 32278444 No abstract available.

10

Long-term survival after low-dose-rate brachytherapy for prostate cancer: the Royal Surrey experience.

Uribe-Lewis S, Uribe J, Bourke V, Deering C, Higgins D, Mehta S, Mikropoulos C, Otter S, Perna C, Khaksar S, Laing R, Langley S. Uribe-Lewis S, et al. Among authors: otter s. BJU Int. 2022 Jun;129(6):723-730. doi: 10.1111/bju.15585. Epub 2021 Sep 22. BJU Int. 2022. PMID: 34448332

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

81 results

Search Page

Filters